ReviewZeitschrift fur Rheumatologie2007
[Immunization in children and adolescents with rheumatic diseases].
Review in Zeitschrift fur Rheumatologie, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 31 citations in OpenAlex.
- Preliminary Case-Control Study of Antibody Response to Vaccines in Children on bDMARDs.Children (Basel, Switzerland) · 2025Article
- Vaccination coverage and its determinants in patients with multiple sclerosis-a multicenter cross-sectional study.Therapeutic advances in neurological disorders · 2025Article
- Vaccination coverage in children with juvenile idiopathic arthritis, inflammatory bowel diseases, and healthy peers: Cross-sectional electronic survey data.World journal of clinical pediatrics · 2023Article
- Vaccination completeness in children with rheumatic diseases: A longitudinal, observational multicenter cohort study in Switzerland.Frontiers in pediatrics · 2022Article
- Vaccinology in pediatric rheumatology: Past, present and future.Frontiers in pediatrics · 2022Review
- The vaccine coverage and vaccine immunity status and risk factors of non-protective levels of antibodies against vaccines in children with juvenile idiopathic arthritis: cross-sectional Russian tertiary Centre study.Pediatric rheumatology online journal · 2021Article
- Immunization of children with secondary immunodeficiency.Human vaccines & immunotherapeutics · 2015Review
- [Medicinal prophylaxis during intensified immunosuppression in children and adolescents : part 2].Zeitschrift fur Rheumatologie · 2013Article
- [Practical problems by implementation of vaccination recommendations].Zeitschrift fur Rheumatologie · 2012Article
- Vaccination coverage in immunosuppressed patients: results of a regional health services research study.Deutsches Arzteblatt international · 2011Article
- Vaccination safety update.Deutsches Arzteblatt international · 2008Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Vaccinations represent a special problem in children and adolescents with inflammatory rheumatic diseases. There are very limited data on the safety and efficacy of vaccines in these patients, and guidelines for immunization are missing. The immunosuppressive therapy often necessary for these patients gives rise to additional uncertainty. In addition, many colleagues consider vaccination to increase the risk of relapse of the rheumatic illness. As a consequence, there are substantial variations in practicing vaccination in these patients, resulting in insufficient vaccination coverage rates. For example, every third patient with juvenile idiopathic arthritis is incompletely vaccinated; this even includes toxoid vaccines for tetanus and diphtheria. The benefit of vaccinations, which far outweighs their potential risks, is well recognized even in patients with autoimmune diseases. These patients in particular require a special protection from infections due to their immunosuppressive therapies. Therefore, children and adolescents with rheumatic diseases should be immunized according to the Standing Immunization Commission of the Robert Koch Institute recommendations whenever possible. However, the time of vaccination must be carefully selected, taking disease activity and treatment into account.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.